Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailiang Xia

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Critical Reviews in Immunology|October 12, 2023
m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid CancerTianyou He, Hailiang Xia, Baojie Chen, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 13, 2024
LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent mannerChaogang Huang, Ziqi Duan, Baojie Chen, et al.
Scientific Reports|December 27, 2024
CDUNeXt: efficient ossification segmentation with large kernel and dual cross gate attentionHailiang Xia, Chuantao Wang, Zhuoyuan Li, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Critical Reviews in Immunology|October 12, 2023
m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid CancerTianyou He, Hailiang Xia, Baojie Chen, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 13, 2024
LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent mannerChaogang Huang, Ziqi Duan, Baojie Chen, et al.
Scientific Reports|December 27, 2024
CDUNeXt: efficient ossification segmentation with large kernel and dual cross gate attentionHailiang Xia, Chuantao Wang, Zhuoyuan Li, et al.
Pageof 1